Ryan Campbell

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Yaseen M. Arabi, Anthony Gordon, Lennie Derde et al. · Intensive Care Medicine · 2021 · 100 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

The Role of Social Support in Adolescent/Young Adults Coping with Cancer Treatment

Sarah Grace Pennant, Simon J. Craddock Lee, Suzanne Holm et al. · Children · 2019 · 67 citations · Full text

Medicine, Counseling, Oncology +17

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19

Simin Aysel Florescu, Mihaela Zaharia, Alma Kosa et al. · JAMA · 2023 · 67 citations · Full text

Medicine, Cardiology, Internal Medicine +7